I'm LongbridgeAI, I can summarize articles.The World Health Organization has granted Emergency Use Listing for Danaher subsidiary Cepheid’s Xpert Hemorrhagic Fever Panel test. This approval facilitates rapid, decentralized molecular testing for the Ebola Bundibugyo outbreak in the Democratic Republic of Congo, providing results in approximately one hour via GeneXpert systems.
- WHO granted Emergency Use Listing for Danaher unit Cepheid’s Xpert Hemorrhagic Fever Panel test for the Ebola Bundibugyo outbreak in the DRC. * Listing enables rapid, decentralized molecular testing on GeneXpert systems, with results in about one hour. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Danaher Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609031200PR_NEWS_USPR_____LA40352) on September 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)